Status:
UNKNOWN
Vitamin K2 and Muscle Weakness in Type 2 Diabetes
Lead Sponsor:
Dasman Diabetes Institute
Collaborating Sponsors:
Kappa Bioscience
Conditions:
Diabete Type 2
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
The aim of the current study is to determine the effects of vitamin K2 supplementation on muscle size and function in adults with muscle weakness and type 2 diabetes.
Eligibility Criteria
Inclusion
- Physician confirmed type 2 diabetes.
- Age \>/= 40 years
- No changes in anti-diabetic medication in the last 3 months.
- Muscle weakness (grip strength \<27kg and females \<16kg)
Exclusion
- BMI of 45 or higher
- BP of 160/100mmHg or higher
- Cancer or cancer that has been in remission \<5 years
- Any medical condition that prevents participants from exercising safely
- On anticoagulant therapy
- Currently consuming vitamin K2 supplements
- Current smoker
Key Trial Info
Start Date :
March 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05375630
Start Date
March 21 2022
End Date
October 1 2024
Last Update
July 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dasman Diabetes Institute
Kuwait City, Kuwait, 15462